MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
0.6360
+0.0045 (0.71%)
At close: Aug 13, 2025, 4:00 PM
0.6400
+0.0040 (0.63%)
After-hours: Aug 13, 2025, 4:00 PM EDT
MetaVia Employees
MetaVia had 9 employees as of December 31, 2024. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$2,054,556
Market Cap
15.39M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MTVA News
- 6 days ago - MetaVia Reports Second Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 7 days ago - MetaVia Extends 48 mg MAD Portion of Its Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity to 8 Weeks and Announces Fifth Weekly Dose in First Patient - PRNewsWire
- 9 days ago - MetaVia Announces AI-Driven Collaboration with Syntekabio to Explore Additional Indications for DA-1241 - PRNewsWire
- 5 weeks ago - MetaVia Doses First Patient in the 48 mg MAD Cohort of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity to Further Explore Maximum Tolerated Dose - PRNewsWire
- 7 weeks ago - MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin at the ADA's 85th Scientific Session - PRNewsWire
- 2 months ago - MetaVia to Present at the Life Sciences Virtual Investor Forum June 12th - GlobeNewsWire
- 2 months ago - MetaVia Announces Poster Presentation on DA-1241 at the ADA's 85th Scientific Sessions - PRNewsWire
- 3 months ago - MetaVia Reports First Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire